TREM2 and neoplasm: Furthermore, LLC CM management promotes the conversion of TREM2+ macrophages to a tumor-promoting M2-like phenotype, suggesting that special molecules in tumor cell-derived CM could regulate the physiological function of TREM2, such as impairing TREM2-mediated phagocytosis.